Keywords: biochem, pharma, starts, phase, ii, troxacitabine, canada

BioChem Pharma starts Phase II troxacitabine

Article | 08 April 1999

Print This

Canada's BioChem Pharma has started Phase II trials of its novelanticancer compound, troxacitabine (formerly BCH-456), for the treatment of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in